Yardany Rafael

Yardany Rafael

Auto-generated profile, based on publicly available information

Yardany Rafael

Affiliation Universidad Pedagógica y Tecnológica de Colombia, Tunja, Colombia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
ECEdgar-Yaset Caicedo
Edgar-Yaset Caicedo
KCKelly Charniga
Kelly Charniga
ARAmanecer Rueda
Amanecer Rueda
IDIlaria Dorigatti
Ilaria Dorigatti
YMYardany Mendez
Yardany Mendez
ZCZulma M. Cucunubá
Zulma M. Cucunubá
Mayaro virus (MAYV) is an arbovirus that is endemic to tropical forests in Central and South America, particularly within the Amazon basin. In recent years, concern has increased regarding MAYV’s ability to invade urban areas and cause epidemics across the region. We conducted a systematic literature review to characterise the evolutionary history of MAYV, its transmission potential, and exposure patterns to the virus. We analysed data from the literature on MAYV infection to produce estimates of key epidemiological parameters, including the generation time and the basic reproduction number, R0. We also estimated the force-of-infection (FOI) in epidemic and endemic settings. Seventy-six publications met our inclusion criteria. Evidence of MAYV infection in humans, animals, or vectors was reported in 14 Latin American countries. Nine countries reported evidence of acute infection in humans confirmed by viral isolation or reverse transcription-PCR (RT-PCR). We identified at least five MAYV outbreaks. Seroprevalence from population based cross-sectional studies ranged from 21% to 72%. The estimated mean generation time of MAYV was 15.2 days (95% CrI: 11.7–19.8) with a standard deviation of 6.3 days (95% CrI: 4.2–9.5). The per-capita risk of MAYV infection (FOI) ranged between 0.01 and 0.05 per year. The mean R0 estimates ranged between 2.1 and 2.9 in the Amazon basin areas and between 1.1 and 1.3 in the regions outside of the Amazon basin. Although MAYV has been identified in urban vectors, there is not yet evidence of sustained urban transmission. MAYV’s enzootic cycle could become established in forested areas within cities similar to yellow fever virus.

1 June 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
YCYaset Caicedo-Ochoa
Yaset Caicedo-Ochoa
DSDavid E Rebellon Sanchez
David E Rebellon Sanchez
MPMarcela Peñaloza-Rallón
Marcela Peñaloza-Rallón
HCHector F. Cortés-Motta
Hector F. Cortés-Motta
YMYardany R. Méndez-Fandiño
Yardany R. Méndez-Fandiño
The coronavirus disease 2019 (COVID-19) has become pandemic and turn in a challenge for Latin America. Understanding the dynamics of the epidemic is essential for decision making, and to reduce the health, economic, and social impacts of the pandemic. The present study aimed to estimate the effective reproductive number (Rt) of Severe Acute Respiratory Syndrome coronavirus 2 (SARS-Cov2) infection during the first 10 days of the outbreak in seven Latin American countries with the highest incidence of cases as of March 23, 2020. Furthermore, we chose to compare the seven countries with Spain and Italy given their history with the virus. Incidence data retrieved from the COVID-19 data repository by Johns Hopkins University were analyzed. The Rt was calculated for the first 10 days of the epidemic in Brazil, Ecuador, Chile, Colombia, Panama, Mexico, and Peru. Rt estimations were compared with Spain and Italy values for the same interval. The median Rt for the first 10 days of the COVID-19 epidemic were 2.90 (2.67-3.14) for Spain and 2.83 (2.7-2.96) for Italy. Latin American Rt estimations were higher in Ecuador (3.95(3.7-4.21)), Panama (3.95(3.7-4.21)), and Brazil (3.95(3.7-4.21)). The smallest one was observed in Peru (2.36(2.11-2.63)). All Latin American countries had Rt greater than 2. The initial stages of the COVID-19 epidemic in Latin America suggested a high Rt. Interventions such as domestic and international travel restrictions, educational institutions closure, social distancing, and intensified case surveillance should be adopted to prevent the collapse of the health systems.

1 June 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
AOAndrés Cuspoca Orduz
Andrés Cuspoca Orduz
LLLaura Lorena Díaz Lache
Laura Lorena Díaz Lache
ACAlvaro Acosta Costilla
Alvaro Acosta Costilla
MPMarcela Katherine Peñaloza
Marcela Katherine Peñaloza
YMYardany Rafael Méndez
Yardany Rafael Méndez
JYJuvenal Yosa
Juvenal Yosa
The coronavirus pandemic is a major public health crisis affecting global health systems with dire socioeconomic consequences, especially in vulnerable regions such as Latin America (LATAM). There is an urgent need for a vaccine to help control contagion, reduce mortality and alleviate social costs. In this study, we propose a rational multi-epitope candidate vaccine against SARS-CoV-2. Using bioinformatics, we constructed a library of potential vaccine peptides, based on the affinity of the most common major human histocompatibility complex (HLA) I and II molecules in the LATAM population to predict immunological complexes among antigenic, non-toxic and non-allergenic peptides extracted from the conserved regions of 92 proteomes. Although HLA-C, had the greatest antigenic peptide capacity from SARS-CoV-2, HLA-B and HLA-A, could be more relevant based on COVID-19 risk of infection in LATAM countries. We also used three-dimensional structures of SARS-CoV-2 proteins to identify potential regions for antibody production. The best HLA-I and II predictions (with increased coverage in common alleles and regions evoking B lymphocyte responses) were grouped into an optimized final multi-epitope construct containing the adjuvants Beta defensin-3, TpD, and PADRE, which are recognized for invoking a safe and specific immune response. Finally, we used Molecular Dynamics to identify the multi-epitope construct which may be a stable target for TLR-4/MD-2. This would prove to be safe and provide the physicochemical requirements for conducting experimental tests around the world.

31 December 2018 in Horizonte Médico (Lima)
Verified
Journal Article
Open access
ECEscuela de Medicina. Tunja Universidad Pedagógica Y Tecnológica de Colombia
Escuela de Medicina. Tunja Universidad Pedagógica Y Tecnológica de Colombia
VLVíctor Lazo
Víctor Lazo
GHGina Hernández
Gina Hernández
RMRafael Méndez
Rafael Méndez

29 May 2019 in Hacia la Promoción de la Salud
Verified
Journal Article
Closed access
FAFred G. Manrique Abril
Fred G. Manrique Abril
GAGiomar Maritza Herrera Amaya
Giomar Maritza Herrera Amaya
YFYardany Rafael Méndez Fandiño
Yardany Rafael Méndez Fandiño
Objetivo: determinar la validez y confiabilidad del Font Roja para medir la satisfacción laboral en profesionales de la salud en Colombia, diseñado por Aranaz y Mira en el año de 1988. Metodología: estudio instrumental psicométrico que determinó la validez facial de contenido y de constructo con métodos estadísticos y confiabilidad del cuestionario. La muestra n=120 para la validez de constructo fue recolectada en diversas ciudades de Colombia por profesionales de enfermería en ejercicio vinculados a instituciones prestadoras de servicios de salud. Resultados: el Font Roja reporta validez superior a 0,71 en contenido y facial, se extrajeron 8 factores que explican el 67,5% de la varianza mediante análisis factorial. El instrumento es fiable con un Alfa de Cronbach de 0,80. Es necesario mantener la escala íntegramente sin suprimir ítems. Conclusión: la versión en español del Font Roja como instrumento de medición de la satisfacción laboral resulta válido y fiable en el contexto colombiano.

2 September 2020 in Research Square
Verified
Preprint
Open access
PDF file
AOAndrés Cuspoca Orduz
Andrés Cuspoca Orduz
LLLaura Lorena Díaz Lache
Laura Lorena Díaz Lache
ACAlvaro Acosta Costilla
Alvaro Acosta Costilla
MPMarcela K. Peñaloza
Marcela K. Peñaloza
YMYardany R. Mendez
Yardany R. Mendez
JYJuvenal Yosa
Juvenal Yosa
The coronavirus pandemic is a major public health crisis affecting global health systems with dire socioeconomic consequences, especially in vulnerable regions such as Latin America. There is an urgent need for a vaccine to help control contagion, reduce mortality and alleviate social costs. In this study, we propose a rational multi-epitope vaccine against SARS-CoV-2. Using bioinformatics, we constructed a library of potential vaccine peptides to predict immunological complexes among antigenic, non-toxic and non-allergenic peptides extracted from the conserved regions of 92 proteomes. We included the most common HLA-I and II molecules in the Latin American population. We also used three-dimensional structures of SARS-CoV-2 proteins to identify potential regions for antibody production. The best HLA-I and II predictions (with increased coverage in common alleles and regions evoking B lymphocyte responses) were grouped into an optimised final construct that meets the necessary safety and physicochemical requirements for conducting experimental tests.